Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and...
Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known t...
Jaqueline Ribas de Melo, Sao Paulo, São Paulo, Brazil
Grenoble University Hospital, Grenoble, France
Dept. of Cardiothoracic and Vascular Surgery, Aarhus, Denmark
Mayo Clinic, Rochester, Minnesota, United States
CHU de Nancy - Hôpital BRABOIS Enfants - Explorations fonctionnelles pédiatriques, Vandœuvre-lès-Nancy, France
Rainbow Babies and Children's Hospital (of Univ. Hospitals Case Med. Center), Cleveland, Ohio, United States
Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan
VA Medical Center, San Francisco, California, United States
University of California San Francisco, San Francisco, California, United States
The Hospital for Sick Children, Toronto, Ontario, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.